[1] |
Cuneo A,Marchetti M,Barosi G,et al.Appropriate use of bendamustine in first-line therapy of chronic lymphocytic leukemia.Recommendations from SIE,SIES,GITMO Group[J].Leukemia Res,2014,38(11):1269-1277.
|
[2] |
Höffken K,Merkle KH,Schönfelder M,et al.Bendamustine as salvage treatment in patients with advanced progressive breast cancer:a phase II study[J].J Cancer Res Clin,1998,124(11):627-632.
|
[3] |
Elefante A, Czuczman MS. Bendamustine for the treatment of indolent non-Hodgkin′s lymphoma and chronic lymphocytic leukemia[J].Am J Health Syst Pharm,2010,67(9):713-723.
|
[4] |
Pönisch W,Dietger N.Bendamustine in the treatment of multiple myeloma:results and future perspectives[J].Semin Oncol,2002,29(4):23-26.
|
[5] |
Liu ZR,Ye XL,Fan GR,et al.Electrospray ionization tandem mass spectrometry analysis of bendamustine hydrochloride[J].Pharm Care Res(药学服务与研究),2012,12(6):414-417.
|
[6] |
Liu ZR,Ye XL,Fan GR.Degradation compounds and their structural confirmation of bendamustine hydrochloride in process of clinical administration[J].Chin J New Drugs Clin Rem(中国新药与临床杂志),2013,32(3):211-216.
|
[7] |
Mathrusri AM,Venkatesh B,Anusha S,et al.Stability-indicating liquid chromatographic method for the determination of bendamustine hydrochloride in parenterals[J].Res J Chem Sci,2012,2(9):72-78.
|
[8] |
Tang H,Wu XM,Peng S.Determination of bendamustine hydrochloride and related substance by HPLC[J].Pharm Clin Res(药学与临床研究),2009,17(4):303-305.
|
[9] |
Kasa S,Reddy MRS.Stability-indicating LC method for the estimation of bendamustine hydrochloride and its related impurities[J].J Chromatogr Sci,2014,52(7):573-583.
|